Fit-for-Purpose Quality Control System in Continuous Bioanalysis During Long-Term Pediatric Studies

Area of Science:

• Pharmacology
• Analytical Chemistry
• Clinical Research

Background:

• Pharmacokinetic (PK) studies are vital for evidence-based pharmacotherapy.
• Bioanalytical data quality directly impacts PK parameter reliability.
• Current guidelines focus on initial validation, neglecting long-term reproducibility.

Purpose of the Study:

• To develop and evaluate a customized quality control system for monitoring bioanalytical runs in pediatric studies.
• To ensure the long-term reproducibility and comparability of bioanalytical data in pediatric pharmacotherapy.

Main Methods:

• Implemented a multi-parameter continuous assessment system including calibration curves, quality control samples, and incurred sample reanalysis.
• Integrated regulatory guidelines with Westgard rules, statistical evaluation, and graphical observations.
• Applied the system to data from three pediatric clinical trials spanning 31 months.

Main Results:

• The developed system identified 16% of analytical runs as invalid.
• Pooled standard deviation provided a reliable estimate of long-term reproducibility (%CV ranging from 3.6% to 10.3%).
• Incurred sample reanalysis met the regulatory requirement of at least 67%.

Conclusions:

• The customized quality control system effectively ensures the reliability and comparability of bioanalytical data in pediatric studies.
• This approach addresses the specific challenges of long-term monitoring in vulnerable pediatric populations.
• The system supports robust evidence-based pharmacotherapy in pediatric research.